Improving the Therapeutic Index of Proinflammatory Cytokines for Cancer Immunotherapy Werewolf Therapeutics, Inc., is an ...

A study of more than 100 patients found that immunotherapy can cure a rare type of cancer in various tumor sites without ...

Immunity is not a function most people particularly associate with the liver. But because of its connection to the gut, the ...

Detailed price information for Bolt Biotherapeutics Inc (BOLT-Q) from The Globe and Mail including charting and trades.

The immune system can work in two ways: the innate immune system reacts to any foreign invaders that are identified by immune cells that look... | Cell And Molecular Biology ...

Researchers have developed an innovative dual-receptor T-cell therapy that promises safer and more effective cancer ...

Ubiquitination, an essential post-translational modification, controls various cellular functions by attaching ubiquitin to proteins, dictating their fate from degradation to functional reorganization ...

During the second half of 2025, Werewolf plans to present interim data from the monotherapy and combination expansion arms, including tolerability, response rate, and durability, and to engage with ...

The leading Merkel Cell Carcinoma Companies such as ImmunityBio, OncoSec Medical, Exelixis, 4SC, Kartos Therapeutics, Incyte ...

Newly discovered oncology drugs called “DNA-encoded tri-specific T-cell engagers,” or “DTriTEs,” engage the immune system ...

Mohammed Milhem, MBBS discussed the mechanism of action of RP1, the design and preliminary findings of the IGNYTE trial in ...

Werewolf Therapeutics, Inc. (the “Company” or “Werewolf”) (Nasdaq: HOWL), an innovative biopharmaceutical company pioneering ...